The FDA has approved lacosamide as add-on therapy for adults with partial-onset seizures, and 2 new dosage strengths of a compound combining levodopa, carbidopa, and entacapone, indicated for Parkinson's disease patients who experience end-of-dose wearing-off.
Medscape Medical News
The noninvasive stimulation technique can improve the use of an individual's nondominant hand, and could help stroke patients recover motor skills.
Medscape Medical News
State pain policies are outdated in a number of areas, influencing clinical decision-making and threatening to impede patient care.
Medscape Neurology & Neurosurgery
In the United States in 2006, more than 20% of all hospital stays were related to mental health, a new report from the Agency for Healthcare Research and Quality shows.
Medscape Medical News
Drs. Mark Freedman, Fred Lublin, and Patricia Coyle review new therapies presented at the 2008 World Congress on Treatment and Research in Multiple Sclerosis held September 17-20 in Montreal, Canada.
Medscape Neurology & Neurosurgery
How will new data on imaging and current and emerging therapies for multiple sclerosis impact clinical practice now or in the future?
What do data suggest are the antiepileptic drugs of choice for pediatric patients with epilepsy?
Important considerations in managing patients with advanced PD are addressed in this interactive, case-based program. Other than motor symptoms, what specific issues should be the focus of treatment?
Medscape Neurology & Neurosurgery
Aggressive phototherapy might provide advantages, a new study shows, but for low-birth-weight infants, treatment might also increase the risk for death, and caution is urged.
Medscape Medical News
Dov Michaeli, MD, PhD, Managing Partner, Madah Medica LLC, Larkspur, California, and of www.thedoctorweighsin.com, explains how 1 chemical makes humans unique.
The Medscape Journal of Medicine